Clinical trial NCT00395226 - References

Rosacea — Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial

Citation(s)

•   ___
  What's New about Zinc. UC Berkeley Wellness Letter. 2004:130:1344S-1349S.
•   Al-Gurairi FT, Al-Waiz M, Sharquie KE
  Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. Br J Dermatol. 2002 Mar;146(3):423-31.
•   Bamford JT
  Rosacea: current thoughts on origin. Semin Cutan Med Surg. 2001 Sep;20(3):199-206. Review.
•   Barceloux DG
  Zinc. J Toxicol Clin Toxicol. 1999;37(2):279-92. Review.
•   Berg M, Lidén S
  An epidemiological study of rosacea. Acta Derm Venereol. 1989;69(5):419-23.
•   Berne B, Venge P, Ohman S
  Perifolliculitis capitis abscedens et suffodiens (Hoffman). Complete healing associated with oral zinc therapy. Arch Dermatol. 1985 Aug;121(8):1028-30.
•   Bikowski JB
  Del Rosso JQ, Goldberg DJ, Margolis DJ, Van Zuuren EJ, Wolf JE. Future Trends in the Treatment of Rosacea. Cutis. 2005;75(Suppl 3):33-36
•   Chandra RK
  Excessive intake of zinc impairs immune responses. JAMA. 1984 Sep 21;252(11):1443-6.
•   Chu A, Huber FJ, Plott RT
  The comparative efficacy of benzoyl peroxide 5%/erythromycin 3% gel and erythromycin 4%/zinc 1.2% solution in the treatment of acne vulgaris. Br J Dermatol. 1997 Feb;136(2):235-8.
•   Dreno B, Amblard P, Agache P, Sirot S, Litoux P
  Low doses of zinc gluconate for inflammatory acne. Acta Derm Venereol. 1989;69(6):541-3.
•   Dreno B, Moyse D, Alirezai M, Amblard P, Auffret N, Beylot C, Bodokh I, Chivot M, Daniel F, Humbert P, Meynadier J, Poli F; Acne Research and Study Group
  Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology. 2001;203(2):135-40.
•   Dreno B, Trossaert M, Boiteau HL, Litoux P
  Zinc salts effects on granulocyte zinc concentration and chemotaxis in acne patients. Acta Derm Venereol. 1992 Aug;72(4):250-2.
•   Fischer Walker C, Black RE
  Zinc and the risk for infectious disease. Annu Rev Nutr. 2004;24:255-75. Review.
•   Fraker PJ, King LE, Laakko T, Vollmer TL
  The dynamic link between the integrity of the immune system and zinc status. J Nutr. 2000 May;130(5S Suppl):1399S-406S. Review.
•   Fraker PJ, King LE
  Reprogramming of the immune system during zinc deficiency. Annu Rev Nutr. 2004;24:277-98. Review.
•   Hambidge M
  Human zinc deficiency. J Nutr. 2000 May;130(5S Suppl):1344S-9S. Review.
•   Hoffman HN 2nd, Phyliky RL, Fleming CR
  Zinc-induced copper deficiency. Gastroenterology. 1988 Feb;94(2):508-12.
•   Irving JA, Mattman A, Lockitch G, Farrell K, Wadsworth LD
  Element of caution: a case of reversible cytopenias associated with excessive zinc supplementation. CMAJ. 2003 Jul 22;169(2):129-31.
•   Meynadier J
  Efficacy and safety study of two zinc gluconate regimens in the treatment of inflammatory acne. Eur J Dermatol. 2000 Jun;10(4):269-73.
•   Millikan L
  The proposed inflammatory pathophysiology of rosacea: implications for treatment. Skinmed. 2003 Jan-Feb;2(1):43-7. Review.
•   Mossad SB, Macknin ML, Medendorp SV, Mason P
  Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study. Ann Intern Med. 1996 Jul 15;125(2):81-8.
•   Rostan EF, DeBuys HV, Madey DL, Pinnell SR
  Evidence supporting zinc as an important antioxidant for skin. Int J Dermatol. 2002 Sep;41(9):606-11. Review.
•   Salzman MB, Smith EM, Koo C
  Excessive oral zinc supplementation. J Pediatr Hematol Oncol. 2002 Oct;24(7):582-4.
•   Schachner L, Eaglstein W, Kittles C, Mertz P
  Topical erythromycin and zinc therapy for acne. J Am Acad Dermatol. 1990 Feb;22(2 Pt 1):253-60.
•   Schosinsky KH, Lehmann HP, Beeler MF
  Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem. 1974 Dec;20(12):1556-63.
•   Sharquie KE, Najim RA, Farjou IB, Al-Timimi DJ
  Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis. Clin Exp Dermatol. 2001 Jan;26(1):21-6.
•   Thiboutot DM
  Acne and rosacea. New and emerging therapies. Dermatol Clin. 2000 Jan;18(1):63-71, viii. Review.
•   Tuleya S
  Research Highlights: Acne and Rosacea Treatments. Skin and Agining.2003;11(8):70-72.
•   Verma KC, Saini AS, Dhamija SK
  Oral zinc sulphate therapy in acne vulgaris: a double-blind trial. Acta Derm Venereol. 1980;60(4):337-40.
•   West EC, Prohaska JR
  Cu,Zn-superoxide dismutase is lower and copper chaperone CCS is higher in erythrocytes of copper-deficient rats and mice. Exp Biol Med (Maywood). 2004 Sep;229(8):756-64.
•   Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, Powell F; National Rosacea Society Expert Committee
  Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004 Jun;50(6):907-12.
•   Wilkin JK
  Rosacea. Pathophysiology and treatment. Arch Dermatol. 1994 Mar;130(3):359-62. Review.

"Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial." Prospective, Double Blind, Randomized, Controlled Trial Comparing the Effects of Supplemental Zinc Sulfate and Placebo on the Severity of Rosacea.

Details for clinical trial NCT00395226